Ozair Alam Selected Research

Therapeutics

4/2022	Nigella sativa L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature.
1/2021	Design, Synthesis, Molecular Docking, and Anticancer Evaluation of Pyrazole Linked Pyrazoline Derivatives with Carbothioamide Tail as EGFR Kinase Inhibitors.
1/2020	Lipid-based nanoformulations in the treatment of neurological disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ozair Alam Research Topics

Disease

10	Neoplasms (Cancer) 07/2022 - 09/2018
3	COVID-19 05/2022 - 01/2022
3	Epilepsy (Aura) 01/2021 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 09/2020
2	Breast Neoplasms (Breast Cancer) 10/2020 - 09/2020
1	Aberrant Crypt Foci 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Retinal Degeneration 11/2021
1	Macular Degeneration (Age-Related Maculopathy) 11/2021
1	Myoclonus (Nocturnal Myoclonus) 01/2021
1	Seizures (Absence Seizure) 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Lung Neoplasms (Lung Cancer) 10/2020
1	Prostatic Neoplasms (Prostate Cancer) 10/2020
1	Hyperglycemia 09/2020
1	Cardiomyopathies (Cardiomyopathy) 04/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Ischemic Stroke 01/2020
1	Disease Progression 01/2020
1	Inflammation (Inflammations) 01/2019
1	Pain (Aches) 01/2019
1	Gout 01/2019
1	Hyperuricemia 01/2019
1	Edema (Dropsy) 12/2018
1	Hypoglycemia (Reactive Hypoglycemia) 04/2018
1	Weight Gain 01/2018

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 07/2022 - 01/2019
2	Biological ProductsIBA 05/2022 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2021 - 04/2020
2	LipidsIBA 01/2020 - 01/2019
2	gamma-Aminobutyric Acid (GABA)IBA 09/2017 - 01/2017
1	Tyrosine Kinase InhibitorsIBA 07/2022
1	neratinibIBA 07/2022
1	Nigella sativa oilIBA 04/2022
1	TubulinIBA 02/2022
1	Dimenhydrinate (DMH)FDA LinkGeneric 01/2022
1	hydrazine (hydrazine dihydrochloride)IBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Antiparasitic Agents (Antiparasitics)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Ivermectin (Mectizan)FDA Link 01/2022
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 11/2021
1	ChitosanIBA 11/2021
1	Sirolimus (Rapamycin)FDA Link 11/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	HMGB1 Protein (HMG1)IBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021
1	pyrazoleIBA 01/2021
1	NitrogenIBA 01/2021
1	fisetinIBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	Heterocyclic Compounds (Compounds, Heterocyclic)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	imidazopyridineIBA 10/2020
1	sulforaphaneIBA 09/2020
1	pentadecanoic acidIBA 09/2020
1	AntioxidantsIBA 09/2020
1	Estrogens (Estrogen)FDA Link 09/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2020
1	Nonesterified Fatty Acids (NEFA)IBA 09/2020
1	Tamoxifen FDA LinkGeneric 09/2020
1	Palmitic Acid (Hexadecanoic Acid)IBA 09/2020
1	DAPIIBA 04/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2020
1	ErbB Receptors (EGF Receptor)IBA 04/2020
1	SynucleinsIBA 01/2020
1	Monoacylglycerol LipasesIBA 01/2019
1	lesinuradIBA 01/2019
1	EnzymesIBA 01/2019
1	Uric Acid (Urate)IBA 01/2019
1	Allopurinol (Remid)FDA LinkGeneric 01/2019
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019
1	CarrageenanIBA 12/2018
1	piperidineIBA 09/2018
1	Rosiglitazone (Avandia)FDA Link 04/2018
1	Pioglitazone (Actos)FDA Link 04/2018
1	Blood Glucose (Blood Sugar)IBA 04/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	TriazinesIBA 09/2017
1	pyrimidineIBA 09/2017

Therapy/Procedure

3	Therapeutics 04/2022 - 01/2020